Daniel J. Lovell

Cincinnati Children's Hospital Medical Center — United States

Medicine · Health Sciences

75h-index23.8kcitations384works4.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Autoimmune and Inflammatory Disorders Research(284), Adolescent and Pediatric Healthcare(166), Acute Lymphoblastic Leukemia research(51), Kawasaki Disease and Coronary Complications(50), Rheumatoid Arthritis Research and Therapies(45)

Publications369 total

Measuring the Impact: MRI Response of Sacroiliac Joints to TNF Inhibitors in Youth with Axial Disease
Arthritis & Rheumatology·2025Open Access
Development and Validation of Minimal Disease Activity, Disease Flare, and Minimal Clinically Important Difference for Children with Chronic Nonbacterial Osteomyelitis Using a Consensus and Data-Driven Approach
2025Open Access
Validation of the Pediatric Arthritis Ultrasound Scoring System for the Elbow, Wrist, and Finger Joints in Children With Juvenile Idiopathic Arthritis
Arthritis Care & Research·2025Open Access
Post-Streptococcal Myositis: Etiology of Myalgia and Severe Inflammation in a Child
PEDIATRICS·2025
Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient‐Reported Outcomes in a Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Withdrawal Trial
Arthritis & Rheumatology·2025Open Access
Impact of Concomitant Methotrexate Use and Prior Biologic Disease‐Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial
ACR Open Rheumatology·2025Open Access
Juvenile Idiopathic Arthritis—The Rubik’s Cube of Pediatric Rheumatology
Children·2025· 1 citedOpen Access
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study
The Journal of Rheumatology·2025Open Access
OP0212 EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH ACTIVE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
Annals of the Rheumatic Diseases·2025Open Access
Core Set of Responsive and Discriminatory Measures for Use in Pragmatic Trials of Youth With Axial Juvenile Spondyloarthritis
Arthritis Care & Research·2025Open Access
Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial
The Journal of Rheumatology·2025· 1 citedOpen Access
Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task force
Annals of the Rheumatic Diseases·2025· 3 citedOpen Access
Comparative Effectiveness and Safety of the <scp>JAK</scp> Inhibitors and Biologic Disease‐Modifying Antirheumatic Drugs in Treating Children With Nonsystemic Juvenile Idiopathic Arthritis: A Bayesian Meta‐Analysis of Randomized Controlled Trials
ACR Open Rheumatology·2025· 1 citedOpen Access
Achieving Medication‐Free Remission in Patients With Juvenile Dermatomyositis
ACR Open Rheumatology·2024· 4 citedOpen Access
25 Years of Biologics for the Treatment of Pediatric Rheumatic Disease: Advances in Prognosis and Ongoing Challenges
Arthritis Care & Research·2024· 7 citedOpen Access
Digital health technology to support patient-centered shared decision making at point of care for juvenile idiopathic arthritis
Frontiers in Pediatrics·2024· 1 citedOpen Access
Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis
Metabolites·2024· 3 citedOpen Access
Validation of the ankle-specific pediatric arthritis ultrasound scoring system in children with juvenile idiopathic arthritis
Seminars in Arthritis and Rheumatism·2024Open Access
Correction: S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis
Arthritis Research & Therapy·2024· 1 citedOpen Access
Using a collaborative learning health system approach to improve disease activity outcomes in children with juvenile idiopathic arthritis in the Pediatric Rheumatology Care and Outcomes Improvement Network
Frontiers in Pediatrics·2024· 4 citedOpen Access
page 1 of 19Next →

Frequent Co-authors

Nicolino Ruperto(20), Alberto Martini(19), Edward H. Giannini(17), Norman T. Ilowite(13), Carol A. Wallace(12), Angelo Ravelli(11), Hermine I. Brunner(11), Andreas Reiff(10), Rayfel Schneider(9), Nico Wulffraat(8), Philip J. Hashkes(7), Peter A. Nigrović(7), Murray H. Passo(7), Fabrizio De Benedetti(6), Alexei A. Grom(6), Timothy Beukelman(6), Yukiko Kimura(6), Kenneth N. Schikler(6), Gerd Horneff(6), Sarah Ringold(6)